ALK GENE MUTATION
Clinical trials for ALK GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ALK GENE MUTATION trials appear
Sign up with your email to follow new studies for ALK GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study seeks best dose of alectinib for ALK-Positive lung cancer patients
Disease control Recruiting nowThis study is for people with advanced ALK-positive non-small cell lung cancer. It tests three different doses of the drug alectinib to find the safest and most effective level. The goal is to control the cancer and measure how the body processes the drug. About 45 participants w…
Matched conditions: ALK GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 26, 2026 10:33 UTC
-
Scientists rebiopsy lung tumors to catch resistance early
Knowledge-focused Recruiting nowThis study looks at why some lung cancers stop responding to targeted therapy. Researchers will take small tumor samples before and after treatment to find early signs of resistance. The goal is to develop better drug combinations that can overcome resistance. About 100 adults wi…
Matched conditions: ALK GENE MUTATION
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 26, 2026 10:41 UTC